Insider Transactions in Q1 2021 at Vor Biopharma Inc. (VOR)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 09
2021
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
BUY
Conversion of derivative security
|
Direct |
3,534
+50.0%
|
-
|
|
Feb 09
2021
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
BUY
Conversion of derivative security
|
Direct |
3,534
+10.77%
|
-
|
|
Feb 09
2021
|
5 Am Ventures Vi, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
555,555
+10.77%
|
$9,999,990
$18.0 P/Share
|
|
Feb 09
2021
|
5 Am Ventures Vi, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
6,136,874
+41.01%
|
-
|
|
Feb 09
2021
|
Alexandria Venture Investments, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
282,804
+50.0%
|
-
|
|
Feb 09
2021
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,979,566
+16.13%
|
$53,632,188
$18.0 P/Share
|
|
Feb 09
2021
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
7,143,025
+46.62%
|
-
|
|
Feb 09
2021
|
Kush Parmar Director |
BUY
Open market or private purchase
|
Indirect |
555,555
+10.77%
|
$9,999,990
$18.0 P/Share
|
|
Feb 09
2021
|
Kush Parmar Director |
BUY
Conversion of derivative security
|
Indirect |
6,136,874
+41.01%
|
-
|